# | Title | Journal | Year | Citations |
---|
1 | A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer | European Urology | 2015 | 320 |
2 | Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial | Journal of Clinical Oncology | 2016 | 264 |
3 | WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation ® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia | Journal of Urology | 2018 | 162 |
4 | Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer | Supportive Care in Cancer | 2016 | 146 |
5 | Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications | Sexual Medicine Reviews | 2019 | 110 |
6 | Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer | British Journal of Cancer | 2001 | 84 |
7 | Cannabis and Male Fertility: A Systematic Review | Journal of Urology | 2019 | 83 |
8 | Cross-Linked Polydimethylsiloxane Injection for Female Stress Urinary Incontinence: Results of a Multicenter, Randomized, Controlled, Single-Blind Study | Journal of Urology | 2009 | 79 |
9 | High Dose Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer | Journal of Urology | 2012 | 79 |
10 | Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity | International Journal of Radiation Oncology Biology Physics | 1999 | 75 |
11 | “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now | Prostate Cancer and Prostatic Diseases | 2020 | 68 |
12 | Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial | BJU International | 2004 | 67 |
13 | Perinatal extravaginal torsion of the testis in the first month of life is a salvageable event | Urology | 2003 | 63 |
14 | Laparoscopic Unroofing of a Renal Cyst | Journal of Urology | 1992 | 60 |
15 | Transobturator tape (TOT): Two years follow-up | Neurourology and Urodynamics | 2007 | 57 |
16 | Similar frequency of testosterone surge after repeat injections of goserelin (Zoladex) 3.6 mg and 10.8 mg: Results of a randomized open-label trial | Urology | 2004 | 54 |
17 | Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up | Urology | 2003 | 53 |
18 | Obesity, body composition, and prostate cancer | BMC Cancer | 2012 | 50 |
19 | Microwave Thermotherapy for Benign Prostatic Hyperplasia with the Dornier Urowave: Results of a Randomized, Double-blind, Multicenter, Sham-controlled Trial | Urology | 1998 | 48 |
20 | Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes | Urology | 2019 | 45 |
21 | Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained | Advances in Therapy | 2019 | 41 |
22 | A Technique for Immediate Realignment and Catheterization of the Disrupted Prostatomembranous Urethra | Journal of Urology | 1989 | 40 |
23 | Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases | Urology | 2005 | 40 |
24 | Topical treatment for acute phase Peyronie’s disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study | International Journal of Impotence Research | 2016 | 35 |
25 | Free-hand transperineal prostate biopsy provides acceptable cancer detection and minimizes risk of infection: evolving experience with a 10-sector template | Urologic Oncology: Seminars and Original Investigations | 2018 | 32 |
26 | Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume | BJU International | 2013 | 29 |
27 | Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial | BJU International | 2019 | 28 |
28 | Transanal endoscopic microsurgery repair of rectourethral fistula after high‐intensity focused ultrasound ablation of prostate cancer | Colorectal Disease | 2011 | 27 |
29 | Role of Prophylactic Antibiotics in Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis | European Urology Open Science | 2022 | 26 |
30 | Recent Advances and Current Role of Transperineal Prostate Biopsy | Urologic Clinics of North America | 2021 | 23 |
31 | Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer – Evidence of effect modification by prostate size | Cancer Letters | 2013 | 20 |
32 | 177Lu‐PSMA radioligand therapy effectiveness in metastatic castration‐resistant prostate cancer: An updated systematic review and meta‐analysis | Prostate | 2022 | 20 |
33 | Ultrasound Guided, Freehand Transperineal Prostate Biopsy: An Alternative to the Transrectal Approach | Urology Practice | 2016 | 18 |
34 | TRITON3: An international, randomized, open-label, phase III study of the PARP inhibitor rucaparib vs. physician’s choice of therapy for patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD). | Journal of Clinical Oncology | 2018 | 17 |
35 | Longitudinal follow‐up and performance validation of an mRNA‐based urine test (Xpert® Bladder Cancer Monitor ) for surveillance in patients with non‐muscle‐invasive bladder cancer | BJU International | 2021 | 16 |
36 | Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer | Clinical Cancer Research | 2022 | 16 |
37 | Polymer‐delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open‐label studies in patients with advanced prostate cancer | BJU International | 2017 | 15 |
38 | Erectile response to vardenafil in men with a history of nonresponse to sildenafil: A time-from-dosing descriptive analysis | Clinical Therapeutics | 2005 | 14 |
39 | Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients | Prostate Cancer and Prostatic Diseases | 2019 | 14 |
40 | Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer | Frontiers in Oncology | 2021 | 14 |
41 | Prenatal bilateral extravaginal testicular torsion?a case presentation | Pediatric Surgery International | 2004 | 12 |
42 | [18F]DCFPyL PET/CT for Imaging of Prostate Cancer | Nuklearmedizin - NuclearMedicine | 2022 | 12 |
43 | IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer | | 2023 | 11 |
44 | Avoiding obsolescence in advanced prostate cancer management: a guide for urologists | BJU International | 2015 | 10 |
45 | Overactive bladder: treatment options in primary care medicine | Journal of the American Osteopathic Association, The | 2007 | 10 |
46 | Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial | Journal of Urology | 2022 | 9 |
47 | Phase 1b/2 study of enzalutamide (ENZ) with LY3023414 (LY) or placebo (PL) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) after progression on abiraterone. | Journal of Clinical Oncology | 2019 | 9 |
48 | Mechanism of Action of the Transobturator Sling for Post-Radical Prostatectomy Incontinence: A Multi-institutional Prospective Study Using Dynamic Magnetic Resonance Imaging | Urology | 2018 | 8 |
49 | Rucaparib plus enzalutamide in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Pharmacokinetics (PK) and safety data from the phase Ib RAMP study. | Journal of Clinical Oncology | 2021 | 6 |
50 | Outcomes of freehand transperineal prostate biopsy with omission of antibiotic prophylaxis | BJU International | 2022 | 6 |